808 related articles for article (PubMed ID: 18578614)
1. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
Michalaki M; Kyriazopoulou V; Paraskevopoulou P; Vagenakis AG; Markou KB
Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
[TBL] [Abstract][Full Text] [Related]
2. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.
Huysmans DA; Nieuwlaat WA; Erdtsieck RJ; Schellekens AP; Bus JW; Bravenboer B; Hermus AR
J Clin Endocrinol Metab; 2000 Oct; 85(10):3592-6. PubMed ID: 11061507
[TBL] [Abstract][Full Text] [Related]
3. Development of hyperthyroidism in nodular goiter and thyroid malignancies in an area of relatively low iodine intake.
Kristensen HL; Vadstrup S; Knudsen N; Siersbaek-Nielsen K
J Endocrinol Invest; 1995 Jan; 18(1):41-3. PubMed ID: 7759783
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of subclinical hyperthyroidism and relationship between thyroid hormonal status and thyroid ultrasonographic parameters in patients with non-toxic nodular goitre.
Rieu M; Bekka S; Sambor B; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1993 Jul; 39(1):67-71. PubMed ID: 8348708
[TBL] [Abstract][Full Text] [Related]
5. Effect of iodine restriction on thyroid function in subclinical hypothyroid patients in an iodine-replete area: a long period observation in a large-scale cohort.
Joung JY; Cho YY; Park SM; Kim TH; Kim NK; Sohn SY; Kim SW; Chung JH
Thyroid; 2014 Sep; 24(9):1361-8. PubMed ID: 24892764
[TBL] [Abstract][Full Text] [Related]
6. Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency.
Rotondi M; Amato G; Del Buono A; Mazziotti G; Manganella G; Biondi B; Sinisi AM; Santini L; Bellastella A; Carella C
Thyroid; 2000 Dec; 10(12):1081-5. PubMed ID: 11201853
[TBL] [Abstract][Full Text] [Related]
7. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
Carlé A; Knudsen N; Pedersen IB; Perrild H; Ovesen L; Rasmussen LB; Laurberg P
Eur J Endocrinol; 2013 Nov; 169(5):537-45. PubMed ID: 23935127
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone-induced thyroid dysfunction in cardiac patients from areas with iodine deficiency.
Trifănescu R; Fica S; Barbu C; Vârtej I; Ursu H; Bunghez R; Coculescu M
Rom J Intern Med; 2004; 42(3):595-605. PubMed ID: 16366133
[TBL] [Abstract][Full Text] [Related]
9. Relationships between serum thyrotropin, serum free thyroxine (T4), and 3,5,3'-triiodothyronine (T3) and the daily T4 and T3 production rates in euthyroid patients with multinodular goiter.
Bregengård C; Kirkegaard C; Faber J; Poulsen S; Hasselstrøm K; Siersbaek-Nielsen K; Friis T
J Clin Endocrinol Metab; 1987 Aug; 65(2):258-61. PubMed ID: 3597707
[TBL] [Abstract][Full Text] [Related]
10. Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study.
Carella C; Mazziotti G; Rotondi M; Del Buono A; Zito G; Sorvillo F; Manganella G; Santini L; Amato G
Clin Endocrinol (Oxf); 2002 Oct; 57(4):507-13. PubMed ID: 12354133
[TBL] [Abstract][Full Text] [Related]
11. Thiamazole Pretreatment Lowers the (131)I Activity Needed to Cure Hyperthyroidism in Patients With Nodular Goiter.
Kyrilli A; Tang BN; Huyge V; Blocklet D; Goldman S; Corvilain B; Moreno-Reyes R
J Clin Endocrinol Metab; 2015 Jun; 100(6):2261-7. PubMed ID: 25867812
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum thyroid hormone, thyrotropin and thyroglobulin concentrations during thyroxine therapy in patients with solitary thyroid nodules.
Morita T; Tamai H; Ohshima A; Komaki G; Matsubayashi S; Kuma K; Nakagawa T
J Clin Endocrinol Metab; 1989 Aug; 69(2):227-30. PubMed ID: 2753971
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
[TBL] [Abstract][Full Text] [Related]
14. Serum thyroid hormone and thyrotropin levels in subjects from endemic goiter regions of New Guinea.
Chopra IJ; Hershman JM; Hornabrook RW
J Clin Endocrinol Metab; 1975 Feb; 40(2):326-33. PubMed ID: 1117981
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune hyperthyroidism occurring late after radioiodine treatment for volume reduction of large multinodular goiters.
Huysmans AK; Hermus RM; Edelbroek MA; Tjabbes T; Oostdijk ; Ross HA; Corstens FH; Kloppenborg PW
Thyroid; 1997 Aug; 7(4):535-9. PubMed ID: 9292939
[TBL] [Abstract][Full Text] [Related]
17. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
18. The lack of nocturnal serum thyrotropin surge in patients with nontoxic nodular goiter may predict the subsequent occurrence of hyperthyroidism.
Bartalena L; Martino E; Velluzzi F; Piga M; Petrini L; Loviselli A; Grasso L; Pinchera A
J Clin Endocrinol Metab; 1991 Sep; 73(3):604-8. PubMed ID: 1874936
[TBL] [Abstract][Full Text] [Related]
19. Suppressive therapy with levothyroxine for euthyroid diffuse and nodular goiter.
Güllü S; Gürses MA; Başkal N; Uysal AR; Kamel AN; Erdoğan G
Endocr J; 1999 Feb; 46(1):221-6. PubMed ID: 10426591
[TBL] [Abstract][Full Text] [Related]
20. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
